Health ❯ Healthcare ❯ Cancer Research

Clinical Trials

Patient Outcomes Targeted Therapy Preclinical Studies Drug Development Therapeutic Innovations Precision Medicine Retrospective Studies NHS Galleri Trial Surveillance Programs Genetic Testing Public Involvement Guideline Development Funding Sources ALASCCA Study Treatment Efficacy Innovative Diagnostics Prostate Cancer Studies Phase II Trials Surgical Oncology Proof-of-Concept Trials Metastasis Prevention Treatment Resistance Molecular Testing TRANSFORM Trial Treatment Options Immunotherapy Saliva Tests for Cancer Olaparib Nivolumab Immunotherapy Research Patient Monitoring Innovative Treatments Funding Impact Study Results Randomized Controlled Trials Targeted Therapies Funding and Support Therapeutic Development Therapeutic Vaccines Patient Representation COMET Study Treatment Strategies Preclinical Research Early Detection Adaptive Trial Designs Patient Disparities Experimental Studies Patient Support Immunotherapy Development Cell Therapy Survival Rates Azenosertib Density MATTERS Trial Aspirin Treatment FDA Approvals Bispecific CAR T Cells Dietary Interventions

UCSF-Led Study Engineers CAR-T Cells In Vivo, Clearing Tumors in Mice

Researchers say the preclinical method now requires scaling followed by human trials.

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

Swedish Study Ties Lower Ipilimumab Dose to Longer Survival and Less Toxicity in Advanced Melanoma

ECOG-ACRIN Review Finds Black AML Patients Have Worse Survival Independent of Cytogenetics

AACR Releases First Pediatric Cancer Progress Report, Citing Record Survival and Persistent Gaps

Targeted Nanoparticles Help Checkpoint Drugs Erase Ovarian Tumors in Mice

Lobular Breast Cancer Is Rising Fast, Now Over 1 in 10 U.S. Cases

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

Adding Molecular Breast Imaging to 3D Mammography Boosts Cancer Detection in Dense Breasts, Major Trial Finds

Low-Dose Aspirin Halves Recurrence in PI3K-Altered Colorectal Cancer, NEJM Trial Finds

AACR’s 2025 Report Shows Cancer Survival Gains as Early-Onset Cases Climb, Presses for Sustained U.S. Funding

Study Finds Extrachromosomal DNA Can Emerge Before Tumors in Glioblastoma

Repurposed Drugs Clear Dormant Breast Cancer Cells in Phase II Trial

Blood Microbial DNA Classifier Accurately Distinguishes Primary Liver Cancer From Colorectal Metastases

EGFR Inhibitors Show Promise Against Immunotherapy-Resistant NF1-Mutant Melanoma